Singapore: Alchemia, an Australian drug discovery and development company, has announced that it has entered into a bind...
Singapore: Medical diagnostics company Universal Biosensors (UBI) published its quarterly cash flow report for the quart...
Singapore: Australia-based specialty pharmaceutical company, Mayne pharma, recently announced plans to invest $65 millio...
Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro d...
Singapore: One of the most challenging tasks ahead of pharmaceutical companies is to create antibodies that are stable e...
Healthcare industry is in a period of evolution accelerated by changing demographics and market forces propelled by insu...
Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new...
Singapore: The New South Wales (NSW) Government in Australia has established a Medical Devices Fund under which it will ...
Singapore: Australia based global medical technology company, Anteo Diagnostics, has entered into a non-exclusive distri...
Singapore: Australia based Anteo Diagnostics has decided to acquire DIAsource ImmunoAssays, (DIAsource), a global specia...
Singapore: Australia-based specialty pharmaceutical company, Hatchtech, has been granted a patent by the US Patent and T...
Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key posit...
Singapore: A prominent healthcare industry leader sounded the alarm over Australia's system for approving government fun...
Singapore: Sunshine Heart, a medical devices company listed on Nasdaq and ASX, has appointed that Mr Jon W Salveson to t...
A Quinquagenarian from Australia, Dr Silviu Itescu, is based out of the US and has been traveling tirelessly between New...
Singapore: Endoscopy devices market in Australia, South Korea, and Southeast Asia, earned revenues of USD264.7 million i...
Singapore: Australian drug delivery technology company, Imugene, has received Japanese patent for its novel drug deliver...
Singapore: Dr Ben-Zion Weiner, special adviser to the CEO of Teva Pharmaceutical Industries, has been appointed as a non...
